Recent research in health decision making has shown that many patients, even those with a college education, have difficulties grasping a host of numerical concepts, including percentages and probabilities. Yet, basic numeracy and graph literacy are essential for understanding information relevant to making decisions about health, such as the incidence and prevalence of different diseases, risk reductions from medical screenings and treatments, and risk increases from side effects of treatments and unhealthy behaviors. Patients who have problems understanding such numerical concepts are often prone to errors in risk perception and medical choices. Importantly, informed medical decision making, heavily reinforced these days by the legal requirement for informed consent, depends critically on communication of quantitative medical information. Meeting the challenge of effectively communicating medical information to patients with different levels of numeracy and graph literacy has become more important than ever. Transparent Communication of Health Risks describes a series of cross-cultural studies investigating how people in countries with different medical and educational systems understand numerical and graphical information, what they know about existing medical treatments and screenings, which presentation formats help them better understand the relevant information, and how they use the data to make medical decisions. Focusing on the careful measurement of necessary knowledge and skills, the book also includes validated numeracy and graph literacy scales in English, Spanish, and German. Some of the topics covered in the book are: numeracy and graph literacy for health; measuring risk comprehension in educated samples; communicating information about medical treatment and screening; reducing the effect of framed messages about health; the effect of individual differences on shared decision making; and transparent health information in the media. Transparent Communication of Health Risks emphasizes the importance and value of working toward the development of tailored risk communication interventions and clarifies the tasks ahead for health psychologists, public health professionals, pharmaceutical and medical education companies, medical physicists, and nurses.

Recent research in health decision making has shown that many patients, even those with a college education, have difficulties grasping a host of numerical concepts, including percentages and probabilities. Yet, basic numeracy and graph literacy are essential for understanding information relevant to making decisions about health, such as the incidence and prevalence of different diseases, risk reductions from medical screenings and treatments, and risk increases from side effects of treatments and unhealthy behaviors. Patients who have problems understanding such numerical concepts are often prone to errors in risk perception and medical choices. Importantly, informed medical decision making, heavily reinforced these days by the legal requirement for informed consent, depends critically on communication of quantitative medical information. Meeting the challenge of effectively communicating medical information to patients with different levels of numeracy and graph literacy has become more important than ever. Transparent Communication of Health Risks describes a series of cross-cultural studies investigating how people in countries with different medical and educational systems understand numerical and graphical information, what they know about existing medical treatments and screenings, which presentation formats help them better understand the relevant information, and how they use the data to make medical decisions. Focusing on the careful measurement of necessary knowledge and skills, the book also includes validated numeracy and graph literacy scales in English, Spanish, and German. Some of the topics covered in the book are: numeracy and graph literacy for health; measuring risk comprehension in educated samples; communicating information about medical treatment and screening; reducing the effect of framed messages about health; the effect of individual differences on shared decision making; and transparent health information in the media. Transparent Communication of Health Risks emphasizes the importance and value of working toward the development of tailored risk communication interventions and clarifies the tasks ahead for health psychologists, public health professionals, pharmaceutical and medical education companies, medical physicists, and nurses.

This book explores the unique contribution that critical communication studies can bring to our understanding of health. It covers several broad themes: representing and mediating health; marketing and promoting health, co-producing health; and managing health crises and risks. Chapters speak to moral and social regulation through health communication, technologies of health, healthism and governmentality. They engage with historical and contemporary issues, offering readers theoretically grounded perspectives. At base, the book explores what a critical communication approach to health might look like, revealing in important—and sometimes surprising—ways how communication sits at the centre of understanding how health is constructed, contested, and made meaningful.

The conventional approach to risk communication, based on a centralized and controlled model, has led to blatant failures in the management of recent safety related events. In parallel, several cases have proved that actors not thought of as risk governance or safety management contributors may play a positive role regarding safety. Building on these two observations and bridging the gap between risk communication and safety practices leads to a new, more societal perspective on risk communication, that allows for smart risk governance and safety management. This book is Open Access under a CC-BY licence.

Research presented at the 7th International Conference on Disaster Management and Human Health: Reducing Risk, Improving Outcomes is contained in this volume. These contributions from academics and experts focus on public health, security and disaster management with the goal to assess the potential risk from various types of disaster and highlight ways to prevent or alleviate any damage. There is a need for academia and practitioners to exchange knowledge and experience on the way to handle the increasing risk of natural and human-made disasters. Recent major earthquakes, tsunamis, hurricanes, floods and other natural phenomena have resulted in huge losses in terms of human life and property destruction. A new range of human-made disasters have afflicted humanity in modern times; terrorist activities have been added to more classical disasters such as those due to the failure of industrial installations for instance. It is important to understand the nature of these global risks to be able to develop strategies to prepare for these events and plan effective responses in terms of disaster management and the associated human health impacts. The papers included in this volume cover such topics as Disaster analysis; Disaster monitoring and mitigation; Emergency preparedness; Risk mitigation; Security decision making; Community recovery and resilience; Socio-economic issues; Public health risk; Disaster psychology; Human factors; Multi-hazard risk assessment; Crisis and communication; Learning from disasters; Terrorism and man-made disasters; Business and service continuity; Disaster risk reduction (DRR); New technologies and tools for disaster evaluation; Disaster governance policies; Environmental issues; Recovery and restoration; Disaster modelling; Surveillance and remote sensing; Disaster response.

The occurrence and spread of an animal health threat can be prevented when a timely assessment of the risk is carried out to inform prevention, response and control measures. These technical guidelines on rapid risk assessment (RRA) are designed as a simple and practical tool to be used by veterinary services to build risk assessment capacities and assist decision-makers in conducting qualitative RRA on the emergence, occurrence and/or spread of animal health threats. Using available evidence, data and information, a multidisciplinary team can conduct an RRA in a short time (within two weeks). The publication provides a simple and flexible methodology for conducting a RRA when facing a disease event. Eight steps in the RRA process are described and detailed examples are provided. The final outcomes of the RRA provide robust evidence and guidance for decision-makers in designing timely prevention, control and eradication measures that contribute to sustainable livelihoods, animal health, public health and enhanced food security.

In response to the coronavirus disease 2019 (COVID-19) pandemic and the societal disruption it has brought, national governments and the international community have invested billions of dollars and immense amounts of human resources to develop a safe and effective vaccine in an unprecedented time frame. Vaccination against this novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), offers the possibility of significantly reducing severe morbidity and mortality and transmission when deployed alongside other public health strategies and improved therapies. Health equity is intertwined with the impact of COVID-19 and there are certain populations that are at increased risk of severe illness or death from COVID-19. In the United States and worldwide, the pandemic is having a disproportionate impact on people who are already disadvantaged by virtue of their race and ethnicity, age, health status, residence, occupation, socioeconomic condition, or other contributing factors. Framework for Equitable Allocation of COVID-19 Vaccine offers an overarching framework for vaccine allocation to assist policy makers in the domestic and global health communities. Built on widely accepted foundational principles and recognizing the distinctive characteristics of COVID-19, this report's recommendations address the commitments needed to implement equitable allocation policies for COVID-19 vaccine.